BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Treatment
20 results:

  • 1. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
    Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
    Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Risk Model for Prognosis and treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition.
    Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
    Shirvaliloo M
    Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer.
    Patel M; Pennel KAF; Quinn JA; Hood H; Chang DK; Biankin AV; Rebus S; Roseweir AK; Park JH; Horgan PG; McMillan DC; Edwards J
    Br J Cancer; 2022 Jun; 126(12):1704-1714. PubMed ID: 35173303
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China.
    Li J; Sun A; Zhong G; He Y; Xiong H; Yuan X
    J Int Med Res; 2021 Nov; 49(11):3000605211061040. PubMed ID: 34851763
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The role of pdgfra as a therapeutic target in young colorectal cancer patients.
    Kim TW; Hong HK; Lee C; Kim S; Lee WY; Yun SH; Kim HC; Huh JW; Park YA; Joung JG; Park WY; Cho YB
    J Transl Med; 2021 Oct; 19(1):446. PubMed ID: 34702313
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].
    Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900
    [No Abstract]    [Full Text] [Related]  

  • 8. Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size.
    Ben Jemii N; Tounsi-Kettiti H; Yaiche H; Mezghanni N; Jaballah Gabteni A; Fehri E; Ben Fayala C; Abdelhak S; Boubaker S
    J Transl Med; 2020 Nov; 18(1):440. PubMed ID: 33213472
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.
    Zhou Y; Zhang X; Wu X; Zhou Y; Zhang B; Liu X; Wu X; Li Y; Shen L; Li J
    Cancer Med; 2020 Sep; 9(17):6225-6233. PubMed ID: 32677196
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PAI1 is a Marker of Bad Prognosis in Rectal cancer but Predicts a Better Response to treatment with PIM Inhibitor AZD1208.
    Muñoz-Galván S; Rivero M; Peinado-Serrano J; Martinez-Pérez J; Fernández-Fernández MC; Ortiz MJ; García-Heredia JM; Carnero A
    Cells; 2020 Apr; 9(5):. PubMed ID: 32344898
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma.
    Yamano T; Kubo S; Tomita N
    Cancer Med; 2020 May; 9(10):3337-3343. PubMed ID: 32168428
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
    Ye ZL; Qiu MZ; Tang T; Wang F; Zhou YX; Lei MJ; Guan WL; He CY
    Cancer Med; 2020 Jan; 9(2):745-756. PubMed ID: 31782259
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
    Reis H; van der Vos KE; Niedworok C; Herold T; Módos O; Szendrői A; Hager T; Ingenwerth M; Vis DJ; Behrendt MA; de Jong J; van der Heijden MS; Peyronnet B; Mathieu R; Wiesweg M; Ablat J; Okon K; Tolkach Y; Keresztes D; Nagy N; Bremmer F; Gaisa NT; Chlosta P; Kriegsmann J; Kovalszky I; Timar J; Kristiansen G; Radzun HJ; Knüchel R; Schuler M; Black PC; Rübben H; Hadaschik BA; Schmid KW; van Rhijn BWG; Nyirády P; Szarvas T
    Int J Cancer; 2018 Oct; 143(7):1764-1773. PubMed ID: 29672836
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.
    Li ZZ; Wang F; Zhang ZC; Wang F; Zhao Q; Zhang DS; Wang FH; Wang ZQ; Luo HY; He MM; Wang DS; Jin Y; Ren C; Qiu MZ; Ren J; Pan ZZ; Li YH; Shao JY; Xu RH
    Oncotarget; 2016 May; 7(19):28356-68. PubMed ID: 27050078
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study.
    Abdul-Jalil KI; Sheehan KM; Toomey S; Schmid J; Prehn J; O'Grady A; Cummins R; O'Neill B; McNamara DA; Deasy J; Breathnach O; Grogan L; Rogers A; Doherty G; Winter D; Ryan J; El-Masry S; Gibbons D; Sheahan K; Gillen P; Kay EW; Hennessy BT
    Ann Surg Oncol; 2014 Aug; 21(8):2642-9. PubMed ID: 24700299
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon.
    Zhou Z; Chen Z; Chen M; Wang R; Yin Y; Yao Y
    Tumour Biol; 2014 May; 35(5):4357-62. PubMed ID: 24375257
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms.
    Bellizzi AM
    Semin Diagn Pathol; 2013 Nov; 30(4):329-61. PubMed ID: 24342289
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation.
    Woźniak A; Rutkowski P; Sciot R; Ruka W; Michej W; Debiec-Rychter M
    Int J Cancer; 2008 May; 122(9):2160-4. PubMed ID: 18183595
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndrome.
    Mandalà M; Pezzica E; Tamborini E; Guerra U; Lagonigro SM; Forloni B; Barni S
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):711-3. PubMed ID: 17625442
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Social determinants of access to reference care centres for patients with colorectal cancer--a multilevel analysis.
    Blais S; Dejardin O; Boutreux S; Launoy G
    Eur J Cancer; 2006 Nov; 42(17):3041-8. PubMed ID: 17029939
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.